IP Library Granted Patent US 10,488,338
Granted Patent B2
US 10,488,338 · App. 14/895,074 · Granted Nov 26, 2019

Methods for assessing fragment lengths of molecular chains using multiple dyes

Inventors: Jared Slobodan (Richmond, CA); Matthew Nesbitt (Langley, CA)
Assignee: Coastal Genomics Inc.
G01N21/6428G01N21/6486G01N27/44726G01N2021/6441
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,488,338
App. No.
14/895,074
Granted
Nov 26, 2019
Kind
B2
Abstract

A method for visualizing and discriminating between DNA/RNA fragment(s) of unknown length(s) and an internal marker(s) of known length in a sample that is disposed in a common electrophoresis gel laneway. The method comprises labeling the DNA/RNA fragment(s) with a first dye and labeling the internal marker(s) with a second dye. The first and second dyes have discrete fluorescent emission spectra, which may be used to visually discriminate the DNA/RNA fragment(s) and the internal marker(s).

Claims (11)

1. A method for visualizing at least one DNA sample fragment or at least one RNA sample fragment separately from at least one internal marker having a length of at least 2500 base pairs and being of a known length, to assist in estimating a DNA fragment length or a RNA fragment length, where the at least one internal marker is in a common electrophoretic laneway with the at least one DNA sample fragment or the at least one RNA sample fragment, the method comprising:

labeling the at least one internal marker having a length of at least 2500 base pairs with a plurality of first dye molecules that exclusively labels the at least one internal marker throughout its length, each of the plurality of first dye molecules being the same and having a first emission spectra when fluoresced by a first excitation means;

labeling the at least one DNA sample fragment or at least one RNA sample fragment with a second dye molecule, the second dye molecule being different from the plurality of first dye molecules and having a second emission spectra when fluoresced by a second excitation means, the second emission spectra being different than the first emission spectra, exciting said laneway with said first excitation means and said second excitation means, and

visualizing the at least one DNA sample fragment or at least one RNA sample fragment when fluoresced by the second excitation means, said visualizing occurring separately from the visualization of the at least one internal marker.

2. The method of claim 1 , wherein the laneway is concurrently excited by the first and second excitation means.

3. The method of claim 1 , wherein the laneway is sequentially excited by the first and second excitation means.

4. The method of claim 1 , wherein the first dye molecule is Cy5.

5. The method of claim 1 , wherein the second dye molecule is Ethidium Bromide or Cy5.

6. The method of claim 1 , wherein the at least one DNA sample fragment or at least one RNA sample fragment is at least one DNA sample fragment.

7. The method of claim 1 , wherein the at least one DNA sample fragment or at least one RNA sample fragment is at least one RNA sample fragment.

8. The method of claim 1 , wherein the electrophoretic laneway is in a slab gel.

Assignments (2)
CHANGE OF NAME Recorded Jan 27, 2022
From: COASTAL GENOMICS INC.
To: YOURGENE HEALTH CANADA INC.
Reel/Frame 058888/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2015
From: SLOBODAN, JARED; NESBITT, MATTHEW
To: COASTAL GENOMICS INC.
Reel/Frame 037177/0973 →
Continuity (2)
Provisional Application 61833823 · Jun 11, 2013
Related Publication 20160123883A1 · May 5, 2016